International Journal of Drug Delivery Technology
Volume 15, Issue 2

Indomethacin-Loaded Nanosponges for Oral Delivery: Formulation Strategy, Optimization, and In-vitro Evaluation

Vipulata P Galankar1,2*, Ganesh D Basarkar1, Chandrashekhar D Upasani3, Sunil V Amrutkar4

1Department of Pharmaceutics, SNJB’s SSDJ College of Pharmacy, Neminagar, Chandwad- 423101, India

2Department of Pharmaceutics, GES’s Sir Dr. M.S. Gosavi College of Pharmaceutical Education and Research, Nashik-422005, India

3Department of Pharmacology, SNJB’s SSDJ College of Pharmacy, Neminagar, Chandwad- 423101, India

4Department of Pharmaceutical Chemistry, GES’s Sir Dr. M.S. Gosavi College of Pharmaceutical Education and Research, Nashik-422005, India 

Received: 16th Mar, 2025; Revised: 27th Apr, 2025; Accepted: 18th May, 2025; Available Online: 25th Jun, 2025 

ABSTRACT

Chronic illnesses like arthritis cause pain and inflammation, requiring extended oral analgesic therapy. To reduce adverse reactions, active pharmaceutical ingredients are administered through sustained-release dosage forms. However, methods like matrix tablets, osmotic systems, and ion exchange resins have limitations. Nanotechnological approaches like nanosponges improve precision and accuracy in medication release manufacturing. Encapsulated formulations offer benefits like reduced side effects, varied dose options, non-irritating properties, and aesthetic appeal. Nanosponges are used in formulation to provide stability, improve bioavailability, alter taste, and target medication distribution systems. β-cyclodextrin-based nanoparticles are used to achieve active pharmaceutical ingredients characteristics. Polymers like ethylcellulose are commonly used for sustained-release formulations. Nanosponges can be synthesized using techniques like solvent technique, cross-linking, ultrasound-assisted preparation, and emulsion solvent diffusion. Ultrasound-assisted method is efficient and cost-effective. The study aims to develop indomethacin-loaded nanoparticles for a sustained-release tablet, obstructing prostaglandin synthesis, a chemical responsible for inflammation and discomfort. Indomethacin, a class II medication, is suitable due to its low solubility and molecular weight.

This study developed and evaluated sustained release preparations of indomethacin-incorporated nanoparticles using EC as a polymer, analyzed physicochemical parameters, and developed a nanoparticle-loaded tablet dosage form.

Keywords: Gout, nanosponges, Indomethacin, sustained-release, β-cyclodextrin, ultrasound-assisted method.

How to cite this article: Vipulata P Galankar, Ganesh D Basarkar, Chandrashekhar D Upasani, Sunil V Amrutkar. Indomethacin-Loaded Nanosponges for Oral Delivery: Formulation Strategy, Optimization, and In-vitro Evaluation. International Journal of Drug Delivery Technology. 2025;15(2):478-84. doi: 10.25258/ijddt.15.2.15

REFERENCES

  1. Raskin JB. Gastrointestinal effects of nonsteroidal anti-inflammatory therapy. The American journal of medicine. 1999 ;106(5):3S-12S. DOI: https://doi.org/10.1016/S0002-9343(99)00112-6.
  2. Dagale M, Gorde N, Shinde K, Karnakoti A, Birajdar P. Current Trends and Challenges in Sustained-Release Tablet Formulations: A Comprehensive Review. International Journal of Scientific Research and Technology. 2025. DOI: 10.5281/zenodo.14678430.
  3. Yusuf E. Pharmacologic and non-pharmacologic treatment of osteoarthritis. Current Treatment Options in Rheumatology. 2016; 2:111-25. DOI: https://doi.org/10.1007/s40674-016-0042-y.
  4. Koppula S, Maddi S. Nanosponges in Therapeutics: Current Advancements and Future Directions in Targeted Drug Delivery. Journal of Drug Delivery Science and Technology. 2024:106258. DOI: https://doi.org/10.1016/j.jddst.2024.106258.
  5. Salunkhe A, More S, Dhole S. A Narrative Review on Drug Loaded Nanosponges as a Carrier for Drug Delivery. International Journal of Pharmaceutical Quality Assurance. 2023;14(1):244-249. DOI: 10.25258/ijpqa.14.1.42.
  6. Patra JK, Das G, Fraceto LF, Campos EV, Rodriguez-Torres MD, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S. Nano based drug delivery systems: recent developments and future prospects. Journal of nanobiotechnology. 2018; 16:1-33. DOI: https://doi.org/10.1186/s12951-018-0392-8.
  7. Kandekar U, Pujari R, Munot N, Chorge T, Lone K, Kamble P, Kishanchand K. Nanosponges-versatile platform as drug carrier. Recent Patents on Nanotechnology. 2023;17(2):91-103.
  8. Garg A, Lai WC, Chopra H, Agrawal R, Singh T, Chaudhary R, Dubey BN. Nanosponge: A promising and intriguing strategy in medical and pharmaceutical Science. Heliyon. 2024; 10(1). DOI: https://doi.org/10.1016/j.heliyon.2023.e23303.
  9. Harish V, Tewari D, Gaur M, Yadav AB, Swaroop S, Bechelany M, Barhoum A. Review on nanoparticles and nanostructured materials: Bioimaging, biosensing, drug delivery, tissue engineering, antimicrobial, and agro-food applications. Nanomaterials. 2022; 12(3):457. DOI: https://doi.org/10.3390/nano12030457.
  10. Bolmal UB, Manvi FV, Kotha R, Palla SS, Paladugu A, Reddy KR. Recent advances in nanosponges as drug delivery system. International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN). 2013;6(1):1934-44. DOI: https://doi.org/10.37285/ijpsn.2013.6.1.3
  11. Tiwari K, Bhattacharya S. The ascension of nanosponges as a drug delivery carrier: preparation, characterization, and applications. Journal of Materials Science: Materials in Medicine. 2022 ;33(3):28. DOI: https://doi.org/10.1007/s10856-022-06652-9.
  12. Desai MM, Jadhav SA, Koparde AA. Nanosponges as a Drug Delivery System: Methods, Characteristics and Applications. International Journal of Drug Delivery Technology. 2024;14(3):1758-1764. DOI: 10.25258/ijddt.14.3.72.
  13. Nalamachu S, Wortmann R. Role of indomethacin in acute pain and inflammation management: a review of the literature. Postgraduate medicine. 2014 ;126(4):92-7. DOI: https://doi.org/10.3810/pgm.2014.07.2787
  14. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arteriosclerosis, thrombosis, and vascular biology. 2011;31(5):986-1000. DOI: https://doi.org/10.1161/ATVBAHA.110.207449.
  15. Dalmoro A, Bochicchio S, Nasibullin SF, Bertoncin P, Lamberti G, Barba AA, Moustafine RI. Polymer-lipid hybrid nanoparticles as enhanced indomethacin delivery systems. European Journal of Pharmaceutical Sciences. 2018 30;121:16-28. DOI: https://doi.org/10.1016/j.ejps.2018.05.014.